MedPath

The Newcastle COPD CBT CARE Study

Not Applicable
Completed
Conditions
Anxiety, depression, respiratory.
Mental and Behavioural Disorders
Registration Number
ISRCTN55206395
Lead Sponsor
ational Institute of Health Research (UK)
Brief Summary

1. 2013 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/24498939 2. 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30479999 (added 21/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
312
Inclusion Criteria

1. Patient with a confirmed diagnosis of COPD (FVC/FEV1 ratio <70%, NICE, 2010)
2. People with all disease severity will be eligible including mild to moderate (FEV1 >50% predicted) and severe to very severe (<50% predicted)
3. Patients with probable anxiety as defined by Hospital Anxiety and Depression Scale Anxiety Subscale (HADSA)
scores >8
4. Willing to participate in the study and able to provide written informed consent
5. Agreed to attend a minimum of 2 and maximum of 6 CBT sessions
6. Target Gender: Male & Female
7. Lower Age Limit 18 years

Exclusion Criteria

1. Patients with HADSA score <8 (within normal range)
2. Patients with known psychosis and personality disorders
3. Patients currently receiving psychological therapy including counselling, psychotherapy including CB
4. Patients unable to engage in CBT e.g. cognitive impairment or dementia)
5. Patients with limited verbal and/or written communication problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Does CBT delivered by respiratory nurses reduce anxiety (1.5 points on HADS scale).; Timepoint(s): At 3 months
Secondary Outcome Measures
NameTimeMethod
<br> 1. Does CBT delivered by respiratory nurses reduced anxiety & depression compared to standard care measured at timepoint(s) 6 & 12 months<br> 2. Reduction in Hospital Anxiety & Depression Scale of at least 1.5 points compared to standard care measured at timepoint(s): 6 months & 12 months<br>
© Copyright 2025. All Rights Reserved by MedPath